CCL22 expression in oral cancer cells was induced by IL-1β secreted by cancer-associated fibroblasts, suggesting a new therapeutic prospect by targeting the IL-1β-CCL22-CCR4 signaling axis for the treatment of oral cancer (117). This evidence concerns the gene CCL22 and cancer.